SequelSEC

BLUE BIOFUELS, INC. BIOF

Industrial Organic Chemicals · CIK 0001549145 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$60.00K
Fiscal year ended 2019-12-31
Operating income
-$1.78M
Fiscal year ended 2019-12-31
Free cash flow
Unavailable
Fiscal year ended 2019-12-31

BLUE BIOFUELS, INC. (BIOF) reported revenue of $60.00K and net income of $1.01M for the fiscal year ended 2019-12-31. This page shows 2 annual periods of income statement, balance sheet and cash flow figures normalized from BLUE BIOFUELS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Organic Chemicals.

Income

BLUE BIOFUELS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312017-12-31
Revenue$60.00K$134.32K
Cost of revenueUnavailableUnavailable
Gross profitUnavailable$134.32K
Operating income-$1.78M-$4.91M
Net income$1.01M-$10.26M
Research & development$797.86K$736.75K
Weighted-average diluted sharesUnavailableUnavailable
Pretax incomeUnavailableUnavailable
Income tax expenseUnavailableUnavailable
Diluted EPSUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailable
General & administrative$1.04M$4.31M
Selling & marketingUnavailableUnavailable

Balance

BLUE BIOFUELS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312017-12-31
Cash & equivalents$110.63K$55.08K
Total assets$609.59K$4.59M
Current assets$213.00K$484.32K
Total liabilities$3.94M$3.81M
Current liabilities$779.02K$3.81M
Total equity incl. NCI-$3.33M$780.26K
Temporary (mezzanine) equityUnavailableUnavailable
InventoryUnavailableUnavailable
Accounts receivableUnavailableUnavailable
GoodwillUnavailableUnavailable
Long-term debtUnavailableUnavailable
Accounts payable$13.97KUnavailable

Cash flow

BLUE BIOFUELS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312017-12-31
Operating cash flow-$1.20M-$1.84M
Capital expendituresUnavailable$8.00K
Investing cash flow-$118.54K-$167.13K
Financing cash flow$1.32M$2.02M
Net change in cash$5.90K$5.40K
Stock-based compensationUnavailableUnavailable
Common dividends paidUnavailableUnavailable
Common share repurchasesUnavailableUnavailable
Depreciation & amortization$31.38K$85.46K

Derived

BLUE BIOFUELS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312017-12-31
Free cash flowUnavailable-$1.85M
Gross marginUnavailable100.0%
Operating margin-2961.1%-3658.4%
FCF marginUnavailable-1379.0%
SBC / revenueUnavailableUnavailable
Current ratio0.27x0.13x
Revenue YoY growthUnavailableUnavailable
Net margin1675.2%-7640.3%
R&D / revenue1329.8%548.5%
CapEx / revenueUnavailable6.0%
Long-term debt / equityUnavailableUnavailable
Effective tax rateUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BIOF in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-04View SEC filing
10-K · Filed 2026-03-19View SEC filing
10-Q · Filed 2025-10-23View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-04-30View SEC filing

Companies in the same industry

ALTO AMTX CDXS CLNV FF GEVO GPRE GWTI IFF LNZA LODE LYB

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.